Connection
Satish Garg to Gastric Inhibitory Polypeptide
This is a "connection" page, showing publications Satish Garg has written about Gastric Inhibitory Polypeptide.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.460 |
|
|
|
-
Snell-Bergeon JK, Kaur G, Renner D, Akturk HK, Beatson C, Garg SK. Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes. Diabetes Technol Ther. 2025 Jan; 27(1):1-9.
Score: 0.236
-
Garg SK, Akturk HK, Kaur G, Beatson C, Snell-Bergeon J. Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes. Diabetes Technol Ther. 2024 Jun; 26(6):367-374.
Score: 0.225